B. Braun Medical, Inc.

August 2, 2019 — B. Braun Interventional Systems Inc. (BIS) announced the U.S. Food and Drug Administration (FDA) has ...

August 02, 2019

November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...

November 02, 2017

August 17, 2015 — The global interventional cardiology devices market is expected to reach $25.16 billion by 2020 ...

August 17, 2015

September 26, 2014 — A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons ...

September 26, 2014

February 22, 2010 – As part of a comarketing and trademark license agreement between MEDRAD Inc. and B. Braun Melsungen ...

February 22, 2010

Feature | Dave Fornell

The focus on balloon angioplasty largely slipped from the interventional limelight a decade ago after the introduction ...

June 23, 2009

October 24, 2007 — Drug-eluting balloons could offer a viable alternative to drug-eluting stents (DES) in the treatment ...

October 24, 2007

Related Content